Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04068142 · ClinicalTrials.gov registry record · NA

The Acceptability and Feasibility of an ED-based, Peer-delivered, Suicide Safety Planning Intervention

A NA study of Suicidal Ideation and Mental Health Issue, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT04068142: Completed NA study of Suicidal Ideation and Mental Health Issue, sponsored by University of Arkansas.

NCT04068142 is a NA study of Suicidal Ideation and Mental Health Issue that has completed, run by University of Arkansas. The registered enrollment target is 37 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04068142, a NA study of Suicidal Ideation and Mental Health Issue, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

Safety planning is a brief, ED-feasible intervention which has been demonstrated to save lives, and has been universally recommended by every recent expert consensus panel on suicide prevention strategies. In one popular version of the safety plan developed by Stanley et al, the patient is encouraged to write out the following items: identifying personal signs of a crisis; helpful internal coping strategies; social contacts or settings which may distract from a crisis; using family members or friends for help when in crisis; mental health professionals who can be contacted when in crisis; and restricting access to lethal means. In most emergency departments, safety-planning is done by clinical personnel such as psychologists or social workers, but these providers are often too busy to perform safety-planning well or have multiple other patient care responsibilities. This study aims to find out if ED patients prefer to complete a safety plan with a peer supporter or clinical personnel. People who are visiting the emergency department for thoughts of self-harm will be asked to participate.

Primary Outcome

Evaluate the number of suicidal ideology (SI) patients approached in the ED who agree to receive a safety plan.

Interventions

  • OTHER Peer Supporter Safety Planning

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2019-11-06
Est. Completion 2021-01-01
Phase NA
University of Arkansas

318 total trials

What the finished NCT04068142 record still lists

NCT04068142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (86% lower).

The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Peer Supporter Safety Planning is the first listed.

NCT04068142 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT04068142 about?

NCT04068142 is a clinical study titled "The Acceptability and Feasibility of an ED-based, Peer-delivered, Suicide Safety Planning Intervention". Safety planning is a brief, ED-feasible intervention which has been demonstrated to save lives, and has been universally recommended by every recent expert consensus panel on suicide prevention strategies. In one popular version of the safety plan developed by Stanley et al, the patient is encourage...

What is the current status of trial NCT04068142?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2019-11-06. Estimated completion is 2021-01-01.

What conditions does trial NCT04068142 study?

This clinical trial studies the following conditions: Suicidal Ideation, Mental Health Issue, Suicide, Attempted.

What interventions are being tested in trial NCT04068142?

The interventions under investigation include: Peer Supporter Safety Planning (OTHER).

Who is sponsoring clinical trial NCT04068142?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04068142 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04068142's enrollment target sits among peer trials

37 77th of 84 higher than 8 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04068142, the US trial registry maintained by the National Library of Medicine. NCT04068142 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.